BRIEF published on 08/22/2024 at 18:05, 1 year 7 months ago ABIONYX Pharma : Bilan du 1er semestre 2024 Chiffre D'affaires Biotechnologie Trésorerie Levée De Fonds ABIONYX Pharma
BRIEF published on 08/22/2024 at 18:05, 1 year 7 months ago ABIONYX Pharma: Review of the first half of 2024 Biotechnology Fundraising Treasury Turnover ABIONYX Pharma
PRESS RELEASE published on 08/22/2024 at 18:00, 1 year 7 months ago Informations privilégiées / Autres communiqués ABIONYX Pharma publie sa position de trésorerie du 1er semestre 2024 avec un chiffre d’affaires consolidé de 2,4 M€. Levée de fonds de 3,4 M€ pour renforcer la trésorerie Chiffre D'affaires Biotechnologie Trésorerie Levée De Fonds ABIONYX Pharma
PRESS RELEASE published on 08/22/2024 at 18:00, 1 year 7 months ago Inside Information / Other news releases ABIONYX Pharma reports €2.4m sales and €5.3m cash position for H1 2024, focused on innovative therapies. Raised €3.4m for sepsis program in the US Sales Cash Position Innovative Therapies ABIONYX Pharma Sepsis
BRIEF published on 07/01/2024 at 09:27, 1 year 9 months ago ABIONYX Successfully Completes €3.4 Million Capital Increase Capital Increase Biotech Shares And Warrants ABIONYX Sepsis Development
BRIEF published on 07/01/2024 at 09:27, 1 year 9 months ago ABIONYX finalise avec succès une augmentation de capital de 3,4 millions d'euros Augmentation De Capital Actions Et Bons De Souscription Biotechnologies ABIONYX Développement De La Septicémie
PRESS RELEASE published on 07/01/2024 at 09:22, 1 year 9 months ago Inside Information / Other news releases ABIONYX successfully completes a capital increase of c.€3.4 million through the issuance of shares with warrants. The fundraising aims to strengthen the company's cash position for its development in sepsis and the United States Fundraising Capital Increase Sepsis ABIONYX Shares With Warrants
BRIEF published on 06/27/2024 at 19:27, 1 year 9 months ago ABIONYX Pharma Achieves Unanimous Approval at Combined General Meeting Shareholders Biotech General Meeting Resolutions ABIONYX Pharma
BRIEF published on 06/27/2024 at 19:27, 1 year 9 months ago ABIONYX Pharma obtient l'approbation unanime de l'Assemblée Générale Mixte Actionnaires Assemblée Générale Resolutions Biotechnologies ABIONYX Pharma
PRESS RELEASE published on 06/27/2024 at 19:22, 1 year 9 months ago Inside Information / Other news releases ABIONYX Pharma announces unanimous approval of all resolutions at its Combined General Meeting. Shareholders renew mandates and approve buyback program Shareholders Buyback Program Renewal Combined General Meeting ABIONYX Pharma
Published on 04/01/2026 at 12:30, 3 minutes ago Critical Elements présente une mise à jour de son programme de forage de 10 000 mètres à rose ouest
Published on 04/01/2026 at 08:05, 4 hours 28 minutes ago Tocvan Discovers New Gold-Silver Zone 1,600 Meters From Main Zone at South Block Gran Pilar; First Aggressive Step-Out Drilling Intersects Mineralization From Surface
Published on 04/01/2026 at 08:00, 4 hours 33 minutes ago Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 04/01/2026 at 04:06, 8 hours 27 minutes ago Jaguar Mining Reports Financial Results for the Fourth Quarter and Full Year 2025
Published on 04/01/2026 at 12:05, 28 minutes ago Kibar Holding Expands Global Footprint with Strategic Investment in the United States
Published on 04/01/2026 at 11:38, 55 minutes ago Mister Spex opens a new store in Hamburg-Bergedorf and continues to drive the profitability of its store network
Published on 04/01/2026 at 11:35, 58 minutes ago Scientists Discover 'Life in a Glass Castle' and Dozens of New Species During Japan Deep-Sea Expedition
Published on 04/01/2026 at 11:28, 1 hour 5 minutes ago Fundamenta Real Estate SA – décisions de l’Assemblée générale et plan de succession du Président du Conseil d’administration
Published on 04/01/2026 at 11:10, 1 hour 23 minutes ago Evotec SE to Announce Fourth Quarter and Full-Year 2025 Results on April 8, 2026
Published on 04/01/2026 at 08:00, 4 hours 33 minutes ago Transfert du contrat de liquidité aupres de Natixis Oddo BHF
Published on 04/01/2026 at 08:00, 4 hours 33 minutes ago Résultats annuels 2025 - ANR par action en hausse de + 8,1 % à 97,10 € - Fonds propres consolidés : 740 M€
Published on 03/31/2026 at 20:08, 16 hours 25 minutes ago SMTPC - Communiqué sur les résultats annuels 2025
Published on 03/31/2026 at 19:05, 17 hours 27 minutes ago SFPI GROUP: implementation of a new liquidity contract
Published on 03/31/2026 at 19:05, 17 hours 27 minutes ago Groupe SFPI : mise en oeuvre d'un nouveau contrat de liquidité
